Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
申请人:CRITITECH, INC.
公开号:US11058639B2
公开(公告)日:2021-07-13
Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, and intracystic injection.
所公开的是通过将局部给药含有抗肿瘤微粒(如紫杉烷微粒)的组合物与全身给药含有免疫治疗剂的组合物相结合来治疗癌症的组合治疗方法。局部给药方法包括局部应用、肺部给药、瘤内注射、腹膜内注射和囊内注射。